Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

585
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
585
Hematopoiesis01:21

Hematopoiesis

7.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

2.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the Safety Profile of Histone Deacetylase Inhibitors in Children with Cancer.

Clinical epigenetics·2026
Same author

Critical care outcomes of hemophagocytic lymphohistiocytosis in children: a single centre retrospective observational study.

Pediatric rheumatology online journal·2026
Same author

Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?

Neuro-oncology advances·2026
Same author

Pediatric High-Grade Gliomas and Cancer Predisposition Syndromes: A Retrospective Study.

HGG advances·2026
Same author

Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS network.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stress.

Nucleic acids research·2026

Related Experiment Video

Updated: Oct 23, 2025

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.8K

GATA2 and marrow failure.

Francesco Fabozzi1, Luisa Strocchio1, Angela Mastronuzzi1

  • 1Department of Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00165, Rome, Italy.

Best Practice & Research. Clinical Haematology
|August 18, 2021
PubMed
Summary
This summary is machine-generated.

GATA2 deficiency, caused by gene mutations, leads to bone marrow failure and diverse symptoms. Allogeneic hematopoietic stem cell transplantation is the only cure, but optimal timing remains unclear.

Keywords:
Bone marrow failureGATA2 deficiencyHematopoietic stem cell transplantationLymphedemaMyelodysplastic syndromesPulmonary alveolar proteinosis

More Related Videos

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.7K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.1K

Related Experiment Videos

Last Updated: Oct 23, 2025

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.8K
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
08:14

Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells

Published on: December 3, 2015

7.7K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.1K

Area of Science:

  • Genetics
  • Hematology
  • Immunology

Background:

  • GATA2 gene mutations cause GATA2 deficiency, a common inherited bone marrow failure syndrome.
  • This condition presents with varied clinical features, including hematological malignancies, immunodeficiency, and organ-specific issues.
  • Symptoms manifest across a wide age range, often emerging during adolescence or early adulthood.

Purpose of the Study:

  • To review the clinical spectrum and management of GATA2 deficiency.
  • To highlight the critical role of hematopoietic stem cell transplantation (HSCT) as a curative treatment.
  • To address the current lack of consensus on HSCT timing for GATA2 deficiency patients.

Main Methods:

  • Literature review of GATA2 deficiency.
  • Analysis of clinical presentations and outcomes.
  • Discussion of treatment options, focusing on HSCT.

Main Results:

  • GATA2 deficiency is linked to significant morbidity and mortality.
  • Allogeneic HSCT effectively restores hematopoietic and immune function and prevents lung disease.
  • There is a need for evidence-based guidelines for HSCT management.

Conclusions:

  • GATA2 deficiency requires comprehensive management strategies.
  • HSCT offers a curative option, but its optimal application needs further definition.
  • Establishing consensus guidelines for HSCT in GATA2 deficiency is crucial for patient care.